Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losenatide vs metformin in newly diagnosed type 2 diabetes mellitus: effects on glucose, lipid and bone metabolism
ChiCTR2200057424Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Apr 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of loxenatide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: HbA1c. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
loxenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2200057424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057424.